Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score.
暂无分享,去创建一个
John P A Ioannidis | George M Spyrou | Evangelos Evangelou | Lars Bertram | Georgios Ntritsos | Kyriaki Antonopoulou | Irene Stefanaki | J. Ioannidis | L. Bertram | E. Evangelou | C. Lill | H. Gogas | G. Spyrou | C. Antoniou | Christina M Lill | Christina Antoniou | K. Kypreou | Katerina P Kypreou | Fani Karagianni | Alexios Zaras | Vasiliki Nikolaou | Iro Kalfa | Vasiliki Chasapi | Dorothea Polydorou | Helen Gogas | Alexander I Stratigos | V. Nikolaou | D. Polydorou | V. Chasapi | I. Stefanaki | Iro Kalfa | G. Ntritsos | A. Stratigos | F. Karagianni | A. Zaras | K. Antonopoulou | Georgios Ntritsos
[1] Marko Hočevar,et al. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma , 2015, Nature Genetics.
[2] Sharon L. R. Kardia,et al. Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes , 2015, Current Epidemiology Reports.
[3] M. Cho,et al. The Role of Genetic Risk Score in Predicting the Risk of Hypertension in the Korean population: Korean Genome and Epidemiology Study , 2015, PloS one.
[4] M. Mendonça,et al. 6C.07: INCREASE THE PREDICTIVE CAPACITY OF CORONARY RISK WITH A GENETIC SCORE , 2015, Journal of Hypertension.
[5] D. Whiteman,et al. Independent validation of six melanoma risk prediction models. , 2015, The Journal of investigative dermatology.
[6] Jane E. Carpenter,et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.
[7] J. Ioannidis,et al. Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database. , 2015, The Journal of investigative dermatology.
[8] Tim K. Lee,et al. Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[9] Thomas M. Keane,et al. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. , 2015, Journal of the National Cancer Institute.
[10] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC medicine.
[11] Gabi Kastenmüller,et al. SNiPA: an interactive, genetic variant-centered annotation browser , 2014, Bioinform..
[12] John P. A. Ioannidis,et al. A Web-based database of genetic association studies in cutaneous melanoma enhanced with network-driven data exploration tools , 2014, Database J. Biol. Databases Curation.
[13] S. Puig,et al. Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions , 2014, International journal of cancer.
[14] D. Polsky,et al. Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance , 2014, PloS one.
[15] Bruce K Armstrong,et al. Risk prediction models for incident primary cutaneous melanoma: a systematic review. , 2014, JAMA dermatology.
[16] X. Hua,et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma , 2014, Nature Genetics.
[17] Thomas M. Keane,et al. POT1 loss-of-function variants predispose to familial melanoma , 2014, Nature Genetics.
[18] Jeffrey E. Lee,et al. Joint Effect of Multiple Common SNPs Predicts Melanoma Susceptibility , 2013, PloS one.
[19] J. Barrett,et al. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study , 2013, BMC Cancer.
[20] J. Ferlay,et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.
[21] Marko Hočevar,et al. A variant in FTO shows association with melanoma risk not due to BMI , 2013, Nature Genetics.
[22] D. Schadendorf,et al. TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.
[23] J. Ioannidis,et al. Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study , 2013, PloS one.
[24] L. Thomas,et al. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants , 2013, Journal of Medical Genetics.
[25] D. Lazovich,et al. Germline melanoma susceptibility and prognostic genes: a review of the literature. , 2012, Journal of the American Academy of Dermatology.
[26] Caitlin P. McHugh,et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. , 2011, Human molecular genetics.
[27] K. Brown,et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.
[28] S. Puig,et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma , 2011, Nature.
[29] Jeffrey E. Lee,et al. Genome-wide association study identifies three new melanoma susceptibility loci , 2011, Nature Genetics.
[30] Jeffrey E. Lee,et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 , 2011, Nature Genetics.
[31] John P A Ioannidis,et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. , 2011, Journal of the National Cancer Institute.
[32] Johnny S. H. Kwan,et al. Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. , 2011, American journal of human genetics.
[33] J. Ioannidis,et al. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement , 2011, BMJ : British Medical Journal.
[34] J. Ioannidis,et al. Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement , 2011, PLoS medicine.
[35] A. Bowcock,et al. Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.
[36] J. Malvehy,et al. Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.
[37] Liuda Ziaugra,et al. SNP Genotyping Using the Sequenom MassARRAY iPLEX Platform , 2009, Current protocols in human genetics.
[38] Nils Homer,et al. Common sequence variants on 20q11.22 confer melanoma susceptibility , 2008, Nature Genetics.
[39] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[40] D. Whiteman,et al. A Risk Prediction Tool for Melanoma? , 2005, Cancer Epidemiology Biomarkers & Prevention.
[41] D. Stoppa-Lyonnet,et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. , 1998, Human molecular genetics.
[42] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.
[43] M. Skolnick,et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.
[44] K. Tanaka,et al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. , 1994, The EMBO journal.
[45] N. Camp,et al. A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q , 2011, Human Genetics.
[46] N. Hayward,et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.